BeautyHealth (NASDAQ:SKIN) Beats Q4 Sales Targets But Full-Year Sales Guidance Misses Expectations Significantly

By Yahoo! Finance   |   2 days ago
BeautyHealth (NASDAQ:SKIN) Beats Q4 Sales Targets But Full-Year Sales Guidance Misses Expectations Significantly

BeautyHealth (NASDAQ:SKIN) exceeded Q4 revenue expectations but experienced a 13.7% sales decline. Despite a disappointing revenue guidance for the next quarter, its Hydrafacial product remains popular in the beauty health sector.

Read More

Did you find this insightful?